BioTime, Inc.

437 articles about BioTime, Inc.

• BioTime Announces the Formation of Embryome Sciences, Inc. for the Development and Commercialization of Stem Cell Technology

  12/12/2007

• BioTime to Present Plans for Regenerative Medicine at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

  11/6/2007

• BioTime Announces Joint Hypothermic Medicine Study With Argonne National Laboratory

  11/2/2007

• BioTime Names Robert W. Peabody Senior Vice President and Chief Operating Officer

  10/23/2007

• BioTime Announces New Line of Credit

  10/18/2007

• BioTime Names Dr. Michael D. West as CEO and Announces Entry Into Stem Cell Research and Regenerative Medicine

  10/12/2007

• BioTime Announces Results for Second Quarter 2007

  8/16/2007

• BioTime To Seek New Marketing Partners For PentaLyte(R); Hospira, Inc. Declined Partnership

  6/14/2007

• BioTime Announces Results for First Quarter 2007

  5/16/2007

• BioTime Announces 2006 Year-End Results

  4/19/2007

• BioTime Announces A Phase II Clinical Trial Of Hextend(R) In Japan

  12/7/2006

• BioTime Announces Results For Second Quarter 2006

  8/16/2006

• BioTime Announces Second Quarter Hextend Revenue

  6/19/2006

• BioTime Announces License Agreement For China And Taiwan

  4/10/2006

• BioTime Raises $1,787,145 In Rights Offer

  12/22/2005

• BioTime Announces Sublicense Arrangement for Japan With Maruishi Pharmaceutical Co., Ltd.

  12/21/2005

• BioTime Announces Appeal Of AMEX Determination

  4/28/2005